Performance of PSA and of PSA density in the diagnosis of prostate carcinoma

Acta Cirurgica Brasileira

Volumn 17, Issue SUPPL. 3, 2002, Pages 7-11

  Martins, Antonio Carlos Pereira ^a   Borelli Bovo, Tiago J ^a   Dos Reis, Rodolfo Borges ^b   Paschoalin, Edson Luiz ^b   Cologna, Adauto José ^a   Suaid, Haylton Jorge ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b Divisão de Urologia ^*

Author keywords

Prostate carcinoma; Prostate specific antigen; PSA; PSA density

Indexed keywords

EID: 52649091839     PISSN: 01028650     EISSN: 16782674     Source Type: Journal    
DOI: 10.1590/s0102-86502002000900002     Document Type: Article

References (10)

1. Ercole CJ, Lange PH, Mathisen M, Chiou RV, Reddy PK, Vessela RL. Prostate-specific antigen and prostatic acid phosphatase in the monitoring and staging of patients with prostatic cancer. J Urol 1987; 138 : 1181-4.
2. Ferro MA, Barnes I, Roberts JBM, Smith PJB. Tumor markers in prostatic carcinoma: a comparison of prostate-specific antigen with acid phosphatase. Br J Urol 1987; 60: 69-73.
3. Stamey TA, Yang N, Hay AR, McNeal JE, Freiha FS, Redwine E. Prostate-specific antigen as a serum marker for adenocarcinoma of the prostate. N Engl J Med 1987; 317: 909-16.
4. Seaman E, Whang M, Olsson CA, Katz A, Cooner WH, Benson MC. PSA density (PSAD): role in patient evaluation and management. Urol Clin North Am 1993; 20: 653-63.
5. Akdas A, Tarcan T, Tur Cevik L, Biren T, Ilker Y, Keri L. The impact of prostate-specific antigen density in predicting prostate cancer when serum prostate-specific antigen levels are less than 10ng/ml. Eur Urol 1996; 29: 189-92.
6. Arcangeli CG, Ornstein DK, Keeth DW, Andriole GL. Prostate-specific antigen as a screening test for prostate cancer. The United States experience. Urol Clin North Am 1997; 24: 299-306.
7. Catalona WJ, Smith DS, Wolfert RL, Wang TJ, Rittenhouse HG, Ratliff TL, Nadler RB. Evaluation of percentage of free serum PSA improve specificity of prostate cancer screening. J.A.M.A. 1995; 274: 1214-20.
8. Haese A, Graefen M, Noldus J, Hammerer P, Huland E, Huland H. Prostatic volume and ratio of free-to-total prostate specific antigen in patients with prostatic cancer or benign prostatic hyperplasia. J Urol 1997; 158: 2188-92.
9. Meyer A, Jung K, Lein M, Rudolph B, Schnorr D, Loening SA. Factors influencing the ratio of free to toal prostate-specifica antigen in serum. Int J Cancer 1997; 74: 630-6.
10. Stephan C, Lein M, Jung K, Lein M, Rudolph B, Schnorr D, Loening SA. The influence of prostate volume on the ratio of free to total prostate specific antigen in serum of patients with prostate carcinoma and benign prostate hyperplasia. Cancer 1997; 79: 104-9.